News

Hope Meely, chief clinical officer at Slope, offers a look into what she believes is the most important clinical trial development over the past five years.

Hope Meely, chief clinical officer at Slope, dives into what she envisions the clinical trial sector to develop in 2023.

Sunny Kumar, MD, partner at GSR Ventures speaks about how healthcare and clinical trials can work together to create a greater impact at the SCOPE 2023 conference in Orlando, FL.

Len Rosenberg, head of clinical operations at Beat AML, reveals how changing the backbone treatment to a different regimen is beneficial to the patient, in terms of the safety with the same efficacy.

Len Rosenberg, head of clinical operations at Beat AML, comments on how factors, such as proper data collection and reporting techniques, can prove to be efficient and help save lives.

Sunny Kumar, MD, partner at GSR Ventures speaks about areas of investment in clinical trials at the SCOPE 2023 conference in Orlando, FL.

Murray L. Aitken, SVP of IQVIA speaks about the requirements of small biopharma clinical development at the SCOPE 2023 conference in Orlando, FL.

Murray L. Aitken, SVP of IQVIA speaks about how biopharma companies can take advantage of present opportunities at the SCOPE 2023 conference in Orlando, FL.

Alliance helps patients manage ePRO and wearables in one place.

Partnership aims to unify solutions on single platform.

SCOPE session discusses key challenges of evaluating potential providers.

Panel at SCOPE discusses applying novel evidence in regulatory decision-making.

The two groups will implement AI technology with an already existing precision medicine trial model.

Panel at SCOPE discusses the possibilities of research in a post-COVID world.

Seagen, an oncology biotech, emphasizes personalization as part of its DE&I strategy.

The sixth annual Young Investigator Draft includes 10 emerging scientists, each of whom will receive a $20,000 unrestricted grant to support their vital work in rare disease research.

Platform unifies eConsent, IRT, and eCOA solutions

Kroger Health, the healthcare division of The Kroger Co., has established its clinical trial site network in conjunction with Kroger's first trial in active recruitment for colorectal cancer gut and immune health observation.

Challenges and strategies for improving representation.

AARDEX Group’s MEMS® dosing capture and analytics system will be integrated with Cambridge Cognition’s Clinpal DCT platform.

Craig Coleman, PharmD, Professor at the University of Connecticut, and the Observational Study in Cancer-Associated Thrombosis for Rivaroxaban (OSCAR) study's principal investigator discusses the ins and outs of the study.

DCTs and RWD among topics for industry to focus on moving into 2023.

Medable's DCT platform selected by Nova Scotia Health to increase the accessibility of oncology care for remote patients in rural Nova Scotia.

Life science technology companies will create an integrated software solution to simplify clinical research activities and improve operational processes.

COTA joins consortium of biopharma companies, data sharing platforms, academic institutions, and service and technology partners.

Guide will help clinical regulators, biopharma, and healthcare organizations to implement the FAIR principles.

New offering includes a DCT platform bundled with site and trial execution services for the DTx market.